Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
The pandemic accelerated our focus on operational resilience and digital transformation.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Doron Blachar is Chief Executive Officer, Ormat Technologies Inc.
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
Investing With Intention In Venture Capital|Ajay Relan,Managing Partner,Slauson & Co
00:00:00
Allergy Therapeutics says US preparations are underway which include two pivotal trials - Manuel Llobert, CEO, Allergy Therapeutics
00:10:00
Charting Your Financial Course: Insights from DeeDee Baze & Pam Dunwald | DeeDee Baze - CEO of Alphemita Financial Services
00:10:00
Partners with exceptional entrepreneurs starting at the earliest stages of the climb|Alex Bard,Managing Director,Redpoint
00:10:00
5 Key Cybersecurity Strategies for Business Preparedness in 2021
00:10:00
Navigating Higher Interest Rates: Strategies and Implications | Morgan Christen, CEO, Spinnaker Investment Group, LLC.
00:10:00
Renato Brunetti, President and CEO of Unidata, shares insights in an interview.
00:10:00
veon CEO Kaan Terzioğlu believes that emerging markets can be more progressive and forward-looking.
00:10:00
Orca's Sudan Gold Project: Navigating Political Challenges for Future Opportunities
00:10:00
Polaris CEO Michael Speetzen commemorates the company's 70th anniversary on May 22, 2024.|Jae-Ho Kim is Director & Head-Management Support at Polaris Office Corp.
00:10:00
First Gen Corp. reported a net income of P15.4 billion in 2023, reflecting strong financial performance.
00:10:00
Allegion Chairman, President, and CEO Dave Petratis has been named a “CEO Who Gets It” by the National Safety Council.|John Stone is president and chief executive officer (CEO) for Allegion, as well as a member of the company’s Board of Directors.